|
| | Publication Year | Title | Author(s) |
| 1 | 8-Oct-2019 | Outcomes of stage I/II follicular lymphoma in the PET era: an international study from the Australian Lymphoma Alliance. | Tobin, Joshua W D; Rule, Gabrielle; Colvin, Katherine; Calvente, Lourdes; Hodgson, David; Bell, Stephen; Dunduru, Chengetai; Gallo, James; Tsang, Erica S; Tan, Xuan; Wong, Jonathan; Pearce, Jessica; Campbell, Robert; Tneh, Shao; Shorten, Sophie; Ng, Melissa; Cochrane, Tara; Tam, Constantine S; Abro, Emad; Hawkes, Eliza A ; Hodges, Georgina; Kansara, Roopesh; Talaulikar, Dipti; Gilbertson, Michael; Johnston, Anna M; Savage, Kerry J; Villa, Diego; Morris, Kirk; Ratnasingam, Sumi; Janowski, Wojt; Kridel, Robert; Cheah, Chan Y; MacManus, Michael; Matigian, Nicholas; Mollee, Peter; Gandhi, Maher K; Hapgood, Greg |
| 2 | Oct-2019 | Comprehensive geriatric assessment is useful in an elderly Australian population with diffuse large B-cell lymphoma receiving rituximab-chemotherapy combinations. | Ong, Doen Ming; Ashby, Michael; Grigg, Andrew P ; Gard, Grace; Ng, Zi Y; Huang, Huayi Ellen; Chong, Yee Shuen; Cheah, Chan Yoon; Devitt, Bianca; Chong, Geoffrey ; Loh, Zoe ; Mo, Allison ; Hawkes, Eliza A |
| 3 | 19-Sep-2019 | Cytarabine-based induction immunochemotherapy in the front-line treatment of older patients with mantle cell lymphoma. | Ratnasingam, Sumita; Casan, Joshua; Shortt, Jake; Hawkes, Eliza A ; Gilbertson, Michael; McQuilten, Zoe; Grigoriadis, George; Htun, Kay Thwe; Htet, Swe Myo; Campbell, Philip; Chai, Khai Li; Quach, Hang; Patil, Sushrut; Opat, Stephen |
| 4 | Mar-2019 | Dose-adjusted EPOCH-R therapy in MYC-rearranged diffuse large B-cell lymphoma: not yet the standard of care. | Casan, Joshua Ml; Barraclough, Allison ; Shortt, Jake; Hawkes, Eliza A |
| 5 | 2019 | Outcomes of synchronous systemic and central nervous system (CNS) involvement of diffuse large B-cell lymphoma are dictated by the CNS disease: a collaborative study of the Australasian Lymphoma Alliance. | Wight, Joel C ; Yue, Mimi; Keane, Colm; Johnston, Anna; Linton, Kim; Chin, Collin; Wai, Shin Hnin; Talaulikar, Dipti; Gasiorowski, Robin; Cheah, Chan Yoon; Gregory, Gareth P; Dickinson, Michael; Minson, Adrian; Coombes, Caitlin; Ku, Matthew; Lam, Stephanie; Hawkes, Eliza A |
| 6 | 2019 | Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical Trials. | Tiu, Crescens; Loh, Zoe ; Gan, Chun Loo; Gan, Hui K ; John, Thomas ; Hawkes, Eliza A |
| 7 | 27-Sep-2018 | Urine cultures at the onset of febrile neutropenia rarely impact antibiotic management in asymptomatic adult cancer patients. | Grigg, Samuel E ; Date, Patrick; Loh, Zoe ; Estacio, Ortis; Johnson, Douglas F; Hawkes, Eliza A ; Grigg, Andrew P |
| 8 | Sep-2018 | Echocardiography has low utility in cancer patients with Staphylococcus aureus bacteraemia: findings from a retrospective study. | Loh, Zoe ; Estacio, Ortis; Grigg, Andrew P ; Holmes, Natasha E ; Chong, Geoff; Hawkes, Eliza A |
| 9 | Jul-2018 | Outcomes following front-line chemotherapy in peripheral T-cell lymphoma: 10-year experience at The Royal Marsden and The Christie Hospital. | Gleeson, Mary; Peckitt, Clare; Cunningham, David; Gibb, Adam; Hawkes, Eliza A ; Back, Morgan; Yasar, Binnaz; Foley, Kate; Lee, Rebecca; Dash, Joanna; Johnson, Hannah; O'Hara, Catherine; Wotherspoon, Andrew; Attygalle, Ayoma; Menasce, Lia; Shenjere, Patrick; Potter, Mike; Ethell, Mark E; Dearden, Claire; Radford, John; Chau, Ian; Linton, Kim |
| 10 | May-2018 | Limited utility of routine chest X-ray in initial evaluation of neutropenic fever in patients with haematological diseases undergoing chemotherapy. | Estacio, Ortis; Loh, Zoe ; Baker, Amy ; Chong, Geoffrey ; Grigg, Andrew P ; Churilov, Leonid ; Hawkes, Eliza A |
| 11 | May-2018 | CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial. | Gleeson, Mary; Peckitt, Clare; To, Ye Mong; Edwards, Laurice; Oates, Jacqueline; Wotherspoon, Andrew; Attygalle, Ayoma D; Zerizer, Imene; Sharma, Bhupinder; Chua, Sue; Begum, Ruwaida; Chau, Ian; Johnson, Peter; Ardeshna, Kirit M; Hawkes, Eliza A ; Macheta, Marian P; Collins, Graham P; Radford, John; Forbes, Adam; Hart, Alistair; Montoto, Silvia; McKay, Pamela; Benstead, Kim; Morley, Nicholas; Kalakonda, Nagesh; Hasan, Yasmin; Turner, Deborah; Cunningham, David |
| 12 | 21-Mar-2018 | Novel Indications for Bruton's Tyrosine Kinase Inhibitors, beyond Hematological Malignancies. | Campbell, Robert; Chong, Geoffrey ; Hawkes, Eliza A |
| 13 | 2018 | Prognostication of diffuse large B-cell lymphoma in the molecular era: moving beyond the IPI. | Wight, Joel C ; Chong, Geoffrey ; Grigg, Andrew P ; Hawkes, Eliza A |
| 14 | 2018 | Routine blood investigations have limited utility in surveillance of aggressive lymphoma in asymptomatic patients in complete remission. | Hawkes, Eliza A ; Loh, Zoe ; Estacio, Ortis; Chong, Geoffrey ; Ha, Francis J; Gilbertson, Michael; Grigg, Andrew P |
| 15 | 2018 | An abscopal effect may augment PD-1 inhibition in refractory classical Hodgkin lymphoma. | Wight, Joel C ; Hawkes, Eliza A ; Berlangieri, Salvatore U ; Khor, Richard ; Grigg, Andrew P |
| 16 | 20-Dec-2017 | Chemoimmunotherapy May Not Be Dead Yet in Chronic Lymphocytic Leukemia, But Fludarabine Plus Cyclophosphamide Plus Rituximab Is Potentially Facing Life Support. | Opat, Stephen; Hawkes, Eliza A |
| 17 | 1-Oct-2017 | Central nervous system relapse of diffuse large B-cell lymphoma in the rituximab era: results of the UK NCRI R-CHOP-14 versus 21 trial. | Gleeson, M; Counsell, Nicholas; Cunningham, D; Chadwick, N; Lawrie, A; Hawkes, Eliza A ; McMillan, A; Ardeshna, K M; Jack, A; Smith, P; Mouncey, P; Pocock, C; Radford, J A; Davies, J; Turner, D; Kruger, A; Johnson, P ; Gambell, J; Linch, D |
| 18 | Aug-2017 | Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003-2013. | Gleeson, Mary; Hawkes, Eliza A ; Peckitt, Clare; Wotherspoon, Andrew; Attygalle, Ayoma; Sharma, Bhupinder; Du, Yong; Ethell, Mark; Potter, Mike; Dearden, Claire; Horwich, Alan; Chau, Ian; Cunningham, David |
| 19 | 1-Jul-2017 | Outcome of elderly patients with diffuse large B-cell lymphoma treated with R-CHOP: results from the UK NCRI R-CHOP14v21 trial with combined analysis of molecular characteristics with the DSHNHL RICOVER-60 trial. | Kühnl, A; Cunningham, D; Counsell, Nicholas; Hawkes, Eliza A ; Qian, W; Smith, P; Chadwick, N; Lawrie, A; Mouncey, P; Jack, A; Pocock, C; Ardeshna, Kirit M; Radford, J; McMillan, A; Davies, J; Turner, D; Kruger, A; Johnson, P W; Gambell, J; Rosenwald, A; Ott, G; Horn, H; Ziepert, M; Pfreundschuh, M; Linch, D |
| 20 | Jun-2017 | Efficacy and toxicity of PACEBOM chemotherapy in relapsed/refractory aggressive lymphoma in the rituximab era | Tamjid, Babak ; Mckendrick, Joseph; Schwarer, Anthony P ; Doig, Rowan; James, Philip; Hosking, Patrick; Hawkes, Eliza A |
Loading...
2
0
20
0
false
0000-0002-0376-2559